Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma

被引:86
作者
Gibson, PG
Simpson, JL
Hankin, R
Powell, H
Henry, RL
机构
[1] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW 2310, Australia
[2] John Hunter Childrens Hosp, Newcastle, NSW 2310, Australia
[3] Univ New S Wales, Sch Womens & Childrens Hlth, Randwick, NSW 2031, Australia
关键词
D O I
10.1136/thorax.58.2.116
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The relationship between the clinical pattern of asthma and airway inflammation in childhood asthma is poorly characterised, yet underpins the treatment recommendations in current asthma guidelines. A study was undertaken to examine the relationship between airway inflammation and clinical asthma in children. Methods: Children with asthma (n = 146) and healthy controls (C, n=37) were recruited from primary and specialist clinics. Sputum induction and hypertonic saline challenge were performed. Results: As the frequency of asthma episodes in the post 12 months increased, there were significant increases in sputum eosinophils (median; infrequent episodic (IE) 1.5%, frequent episodic (FE) 2.3%, persistent (P) 3.8%, control (C) 1.0%; p=0.002), sputum eosinophil cationic protein (ECP) (IE 113 ng/ml, FE 220, P 375, C 139; p=0.003), and desquamated bronchial epithelial cells (IE 2.0%, FE 6.0%, P 5.0%, C 2.5%; p=0.04). Treatment intensity was also associated with increased sputum eosinophils (p=0.005). The relationships between other severity markers (current symptoms, lung function) were less strong. Conclusion: Children with more frequent episodes of clinical asthma exhibit increasing airway inflammation that is characterised by sputum eosinophilia and bronchial epithelial desquamation. The results support clinical assessment by frequency of wheezing episodes over the past 12 months when determining anti-inflammatory treatment requirements, and indicate that current symptoms are determined by mechanisms in addition to sputum eosinophilia.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 29 条
[1]   Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine [J].
Boulet, LP ;
Laviolette, M ;
Turcotte, H ;
Cartier, A ;
Dugas, M ;
Malo, JL ;
Boutet, M .
CHEST, 1997, 112 (01) :45-52
[2]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[3]   Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children [J].
Cai, Y ;
Carty, K ;
Henry, RL ;
Gibson, PG .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (04) :848-853
[4]   Asthma control versus asthma severity [J].
Cockcroft, DW ;
Swystun, VA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :1016-1018
[5]   Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma [J].
Crimi, E ;
Spanevello, A ;
Neri, M ;
Ind, PW ;
Rossi, GA ;
Brusasco, V .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :4-9
[6]   Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood [J].
Gibson, PG ;
Wlodarczyk, JW ;
Hensley, MJ ;
Gleeson, M ;
Henry, RL ;
Cripps, AW ;
Clancy, RL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) :36-41
[7]  
Gibson PG, 2000, EUR RESPIR J, V16, P1008
[8]   Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma [J].
Gibson, PG ;
Saltos, N ;
Borgas, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (04) :752-759
[9]   Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity [J].
Grootendorst, DC ;
van den Bos, JW ;
Romeijn, JJ ;
Veselic-Charvat, M ;
Duiverman, EJ ;
Vrijlandt, EJLE ;
Sterk, PJ ;
Roldaan, AC .
EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (03) :647-653
[10]  
IRELAND MJ, 1997, CLIN EXP ALLERGY, V24, P940